Replies to post #93367 on Cytodyn Inc (CYDY)

[EponymousKook]

And in the end it won’t even matter if we’re not first to market for covid. Approval is coming very soon, and that will derisk all the other indications in our pipeline — just as HIV revenue starts paying the bills. It will mark the long-awaited inflection point, when Leronlimab can no longer be denied.